Detection of differentiated thyroid carcinoma in exhaled breath with an electronic nose
Publication date
2022-06-21
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
cc_by
Abstract
This proof-of-principle study investigates the diagnostic performance of the Aeonose in differentiating malignant from benign thyroid diseases based on volatile organic compound analysis in exhaled breath. All patients with a suspicious thyroid nodule planned for surgery, exhaled in the Aeonose. Definitive diagnosis was provided by histopathological determination after surgical resection. Breath samples were analyzed utilizing artificial neural networking. About 133 participants were included, 48 of whom were diagnosed with well-differentiated thyroid cancer. A sensitivity of 0.73 and a negative predictive value (NPV) of 0.82 were found. The sensitivity and NPV improved to 0.94 and 0.95 respectively after adding clinical variables via multivariate logistic regression analysis. This study demonstrates the feasibility of the Aeonose to discriminate between malignant and benign thyroid disease. With a high NPV, low cost, and non-invasive nature, the Aeonose may be a promising diagnostic tool in the detection of thyroid cancer.
Keywords
Breath Tests, Electronic Nose, Exhalation, Humans, Thyroid Neoplasms/diagnosis, Volatile Organic Compounds/analysis, thyroid carcinoma, volatile organic compounds, electronic nose, exhaled air, innovative diagnostics, Pulmonary and Respiratory Medicine, Journal Article
Citation
Scheepers, M H M C, Al-Difaie, Z J J, Wintjens, A G W E, Engelen, S M E, Havekes, B, Lubbers, T, Coolsen, M M E, van der Palen, J, van Ginhoven, T M, Vriens, M & Bouvy, N D 2022, 'Detection of differentiated thyroid carcinoma in exhaled breath with an electronic nose', Journal of Breath Research, vol. 16, no. 3, 036008. https://doi.org/10.1088/1752-7163/ac77a9